{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:13:07Z","timestamp":1772842387524,"version":"3.50.1"},"reference-count":42,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,2,16]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pleural infection remains a major cause of morbidity and mortality, with a significant healthcare burden. Despite growing research and guideline recommendations, real-world management continues to vary widely.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An anonymous cross-sectional survey evaluating current practice was conducted among respiratory physicians across all public hospitals in Singapore. The survey examined key aspects of management, including pleural fluid diagnostics, chest drain management, surgical referral and intrapleural fibrinolytic therapy (IPFT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>95 respondents (58% response rate) completed the survey. Only 36.8% routinely inoculate pleural fluid into both plain specimen bottles and blood culture bottles, and up to 22% used plain tubes for pH analysis. Opinions on pH-guided chest drain insertion were divided: 50.6% would always consider pH, while 43.1% did not find it useful. IPFT was regarded as first line treatment following failure of standard care (antibiotics and chest drainage) by 63.2%, while 30.5% would only administer IPFT when surgery was deemed unsuitable. Most respondents (81.0%) had used a reduced dose of tissue plasminogen activator, with 12.6% doing so for all patients. The most common reduced dose was 5 mg (73.7%), largely driven by perceived reduction in bleeding risk (64.2%). Once-daily IPFT dosing was reported by 35.8%, primarily due to logistical constraints and safety concerns related to after-hours administration. Management practices, including pleural fluid sampling for microbiology and pH, indication and timing of surgery or IPFT, and IPFT dose adjustment, varied substantially between hospitals and between individual physicians within the same hospital, with no clear association with respondent seniority. Overall key challenges cited included variation in practice (48.4%), limited after-office hours expertise (44.2%) and limited surgical support (37.9%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Significant variation exists in pleural infection management across Singapore. Strengthening multidisciplinary collaboration, establishing dedicated pleural services and high-quality trials are needed to optimise care pathways.\n                      <jats:named-content content-type=\"\">Cite Now<\/jats:named-content>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003968","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:35:12Z","timestamp":1772807712000},"page":"e003968","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Managing pleural infections: a nationwide survey of respiratory physicians in Singapore"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5243-5167","authenticated-orcid":false,"given":"Ken Junyang","family":"Goh","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn Khai Wern","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipika","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Medicine, Ng Teng Fong General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan Jia Jun","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Medicine, Khoo Teck Puat Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Fong","sequence":"additional","affiliation":[{"name":"Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, Singapore"},{"name":"Division of Respiratory and Critical Care Medicine, Department of Medicine, Alexandra Health Pte Ltd, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0131-6269","authenticated-orcid":false,"given":"Si Ling","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6072-5277","authenticated-orcid":false,"given":"Brian Lee Wei","family":"Chua","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao Li","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Shyuan","family":"Siow","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Woodlands Health, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Sengkang General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran Bin","family":"Mohamed Noor","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wui Mei","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"2026030606350763000_13.1.e003968.1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.156406"},{"key":"2026030606350763000_13.1.e003968.2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03546-2020","article-title":"Epidemiology of pleural empyema in English hospitals and the impact of influenza","volume":"57","author":"Arnold","year":"2021","journal-title":"Eur Respir J"},{"key":"2026030606350763000_13.1.e003968.3","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/975312"},{"key":"2026030606350763000_13.1.e003968.4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215267"},{"key":"2026030606350763000_13.1.e003968.5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/resp.13395","article-title":"Bacteriology and clinical outcomes of patients with culture-positive pleural infection in Western Australia: A 6-year analysis","volume":"24","author":"Brims","year":"2019","journal-title":"Respirology"},{"key":"2026030606350763000_13.1.e003968.6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1378\/chest.13-1912","article-title":"Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study","volume":"145","author":"S\u00f8gaard","year":"2014","journal-title":"Chest"},{"key":"2026030606350763000_13.1.e003968.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.05.026"},{"key":"2026030606350763000_13.1.e003968.8","doi-asserted-by":"crossref","first-page":"00590","DOI":"10.1183\/23120541.00590-2021","article-title":"An international survey on the use of intrapleural tissue plasminogen activator\/DNase therapy for pleural infection","volume":"8","author":"Lau","year":"2022","journal-title":"ERJ Open Res"},{"key":"2026030606350763000_13.1.e003968.9","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219698"},{"key":"2026030606350763000_13.1.e003968.10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S2213-2600(20)30533-6","article-title":"Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement","volume":"9","author":"Chaddha","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026030606350763000_13.1.e003968.11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01062-2022","article-title":"ERS\/ESTS statement on the management of pleural infection in adults","volume":"61","author":"Bedawi","year":"2023","journal-title":"Eur Respir J"},{"key":"2026030606350763000_13.1.e003968.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042473"},{"key":"2026030606350763000_13.1.e003968.13","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.5.9903002"},{"key":"2026030606350763000_13.1.e003968.14","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.157842"},{"key":"2026030606350763000_13.1.e003968.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200801-062OC"},{"key":"2026030606350763000_13.1.e003968.16","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.151.6.7767510"},{"key":"2026030606350763000_13.1.e003968.17","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.6.2022"},{"key":"2026030606350763000_13.1.e003968.18","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1164\/rccm.201911-2169OC","article-title":"Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions","volume":"201","author":"Arnold","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030606350763000_13.1.e003968.19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.202206-1084OC","article-title":"The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study","volume":"207","author":"Bedawi","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030606350763000_13.1.e003968.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1044"},{"key":"2026030606350763000_13.1.e003968.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012740"},{"key":"2026030606350763000_13.1.e003968.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2008.01296.x"},{"key":"2026030606350763000_13.1.e003968.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00147214"},{"key":"2026030606350763000_13.1.e003968.24","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6340851","article-title":"A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection","volume":"2023","author":"Goh","year":"2023","journal-title":"Pulm Med"},{"key":"2026030606350763000_13.1.e003968.25","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1016\/S2666-5247(21)00327-X","article-title":"The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing","volume":"3","author":"Kanellakis","year":"2022","journal-title":"Lancet Microbe"},{"key":"2026030606350763000_13.1.e003968.26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccm.2025.02.003","article-title":"Management of Parapneumonic Effusion and Empyema","volume":"46","author":"Bhatnagar","year":"2025","journal-title":"Clin Chest Med"},{"key":"2026030606350763000_13.1.e003968.27","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.jtcvs.2017.01.030","article-title":"The American Association for Thoracic Surgery consensus guidelines for the management of empyema","volume":"153","author":"Shen","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026030606350763000_13.1.e003968.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.06.013"},{"key":"2026030606350763000_13.1.e003968.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.12.031"},{"key":"2026030606350763000_13.1.e003968.30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1164\/rccm.202305-0854OC","article-title":"Early Video-assisted Thoracoscopic Surgery or Intrapleural Enzyme Therapy in Pleural Infection: A Feasibility Randomized Controlled Trial. The Third Multicenter Intrapleural Sepsis Trial-MIST-3","volume":"208","author":"Bedawi","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030606350763000_13.1.e003968.31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00130-2020","article-title":"Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study","volume":"56","author":"Corcoran","year":"2020","journal-title":"Eur Respir J"},{"key":"2026030606350763000_13.1.e003968.32","article-title":"Validation of the RAPID score in a Danish population with pleural infection","volume":"71","author":"Hansen","year":"2024","journal-title":"Dan Med J"},{"key":"2026030606350763000_13.1.e003968.33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.47102\/annals-acadmedsg.2024276","article-title":"Intrapleural fibrinolytic therapy for pleural infections: Outcomes from a cohort study","volume":"53","author":"Yong","year":"2024","journal-title":"Ann Acad Med Singap"},{"key":"2026030606350763000_13.1.e003968.34","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.chest.2022.06.008","article-title":"Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection: An International, Multicenter, Retrospective Cohort Study","volume":"162","author":"Akulian","year":"2022","journal-title":"Chest"},{"key":"2026030606350763000_13.1.e003968.35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1513\/AnnalsATS.201609-673OC","article-title":"Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project","volume":"14","author":"Popowicz","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026030606350763000_13.1.e003968.36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/resp.14261","article-title":"Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose","volume":"27","author":"Popowicz","year":"2022","journal-title":"Respirology"},{"key":"2026030606350763000_13.1.e003968.37","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2020.43","article-title":"Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management","volume":"16","author":"Chong","year":"2021","journal-title":"Eur Cardiol"},{"key":"2026030606350763000_13.1.e003968.38","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1718729"},{"key":"2026030606350763000_13.1.e003968.39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000443334","article-title":"Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease","volume":"91","author":"Mehta","year":"2016","journal-title":"Respiration"},{"key":"2026030606350763000_13.1.e003968.40","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-020-05210-2","article-title":"Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study","volume":"13","author":"Jiang","year":"2020","journal-title":"BMC Res Notes"},{"key":"2026030606350763000_13.1.e003968.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-021-01492-9","article-title":"Medical thoracoscopy treatment for pleural infections: a systematic review and meta-analysis","volume":"21","author":"Mondoni","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2026030606350763000_13.1.e003968.42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12890-022-02126-4","article-title":"A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trial","volume":"22","author":"Arnold","year":"2022","journal-title":"BMC Pulm Med"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:35:16Z","timestamp":1772807716000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,6]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjresp-2025-003968"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003968","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}